An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for CORCEPT THERAPEUTICS Inc
| Ticker | CORT |
| FIGI | BBG000BKJG33 |
| CUSIP | 218352102 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 271 / 4.0% |
| Percentage held by institutional investors | 82.7% |
About
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia